A detailed history of Sei Investments CO transactions in Amgen Inc stock. As of the latest transaction made, Sei Investments CO holds 374,424 shares of AMGN stock, worth $117 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
374,424
Previous 377,711 0.87%
Holding current value
$117 Million
Previous $109 Million 2.14%
% of portfolio
0.16%
Previous 0.18%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$268.87 - $324.56 $883,775 - $1.07 Million
-3,287 Reduced 0.87%
374,424 $106 Million
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $13.3 Million - $15 Million
51,982 Added 15.96%
377,711 $109 Million
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $1.19 Million - $1.48 Million
5,435 Added 1.7%
325,729 $87.5 Million
Q2 2023

Aug 11, 2023

SELL
$214.27 - $253.37 $6.52 Million - $7.71 Million
-30,439 Reduced 8.68%
320,294 $71.1 Million
Q1 2023

May 12, 2023

BUY
$225.79 - $275.2 $2.09 Million - $2.55 Million
9,268 Added 2.71%
350,733 $84.8 Million
Q4 2022

Feb 10, 2023

BUY
$229.03 - $291.01 $2.63 Million - $3.35 Million
11,499 Added 3.48%
341,465 $89.7 Million
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $825,339 - $930,832
-3,677 Reduced 1.1%
329,966 $74.4 Million
Q2 2022

Aug 15, 2022

BUY
$230.71 - $256.74 $974,519 - $1.08 Million
4,224 Added 1.28%
333,643 $81 Million
Q1 2022

May 13, 2022

SELL
$219.27 - $242.57 $1.97 Million - $2.18 Million
-8,989 Reduced 2.66%
329,419 $79.5 Million
Q4 2021

Feb 14, 2022

SELL
$198.88 - $227.6 $2.72 Million - $3.11 Million
-13,656 Reduced 3.88%
338,408 $76.1 Million
Q3 2021

Nov 12, 2021

BUY
$212.27 - $248.7 $1.89 Million - $2.21 Million
8,897 Added 2.59%
352,064 $74.8 Million
Q2 2021

Aug 06, 2021

BUY
$233.58 - $259.14 $1.2 Million - $1.34 Million
5,153 Added 1.52%
343,167 $83.5 Million
Q1 2021

May 12, 2021

BUY
$221.91 - $258.6 $9.76 Million - $11.4 Million
43,998 Added 14.96%
338,014 $82.3 Million
Q4 2020

Feb 08, 2021

BUY
$216.38 - $257.67 $4.38 Million - $5.21 Million
20,230 Added 7.39%
294,016 $67.6 Million
Q3 2020

Dec 04, 2020

SELL
$234.65 - $260.95 $2.45 Million - $2.73 Million
-10,453 Reduced 3.68%
273,786 $69.8 Million
Q3 2020

Nov 06, 2020

SELL
$234.65 - $260.95 $6.34 Million - $7.06 Million
-27,040 Reduced 8.69%
284,239 $72.4 Million
Q2 2020

Aug 17, 2020

SELL
$197.81 - $242.74 $19.8 Million - $24.2 Million
-99,872 Reduced 24.29%
311,279 $73.3 Million
Q2 2020

Aug 11, 2020

BUY
$197.81 - $242.74 $172,094 - $211,183
870 Added 0.21%
411,151 $98.5 Million
Q1 2020

May 14, 2020

SELL
$182.24 - $241.7 $2.25 Million - $2.99 Million
-12,359 Reduced 2.92%
410,281 $83.1 Million
Q4 2019

Feb 06, 2020

BUY
$189.21 - $243.2 $4.63 Million - $5.95 Million
24,460 Added 6.14%
422,640 $102 Million
Q3 2019

Nov 12, 2019

BUY
$174.11 - $208.62 $20.5 Million - $24.6 Million
117,850 Added 42.04%
398,180 $77.1 Million
Q2 2019

Aug 14, 2019

SELL
$166.7 - $195.41 $6.86 Million - $8.05 Million
-41,172 Reduced 12.81%
280,330 $51.6 Million
Q1 2019

May 15, 2019

BUY
$180.87 - $203.88 $4.74 Million - $5.34 Million
26,198 Added 8.87%
321,502 $61.1 Million
Q4 2018

Feb 13, 2019

BUY
$178.4 - $208.25 $10.9 Million - $12.8 Million
61,242 Added 26.16%
295,304 $60.2 Million
Q3 2018

Nov 08, 2018

SELL
$185.29 - $208.89 $2.81 Million - $3.17 Million
-15,160 Reduced 6.08%
234,062 $48.5 Million
Q2 2018

Aug 03, 2018

BUY
$166.05 - $186.51 $28.4 Million - $31.9 Million
171,260 Added 219.67%
249,222 $46 Million
Q1 2018

May 11, 2018

SELL
$169.43 - $198.0 $41.5 Million - $48.4 Million
-244,673 Reduced 75.84%
77,962 $13.3 Million
Q4 2017

Feb 08, 2018

BUY
$168.79 - $188.59 $1.37 Million - $1.53 Million
8,111 Added 2.58%
322,635 $51.8 Million
Q3 2017

Nov 06, 2017

BUY
$167.29 - $191.0 $52.6 Million - $60.1 Million
314,524
314,524 $58.6 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $167B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.